Medford, MA, United States of America

Anuj K Kuldipkumar



 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anuj K Kuldipkumar: Innovator in Pharmaceutical Sciences

Introduction

Anuj K Kuldipkumar is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug formulations. With a total of six patents to his name, Kuldipkumar's work focuses on enhancing the efficacy of pharmaceutical compounds.

Latest Patents

Kuldipkumar's latest patents include advancements in solid forms of a thiophosphoramidate nucleotide prodrug. His applications relate to the solid-state forms, specifically crystalline forms of 2'-C-methyluridine-5′-(O-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate. These patents detail pharmaceutical compositions that incorporate these solid forms and outline methods for treating or ameliorating various diseases and conditions using these innovative compounds. Additionally, he has disclosed methods for combining these solid forms with other agents to enhance therapeutic outcomes.

Career Highlights

Throughout his career, Kuldipkumar has worked with prominent companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Alios Biopharma, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of Kuldipkumar's notable coworkers include Ales Medek and Lori Ann Ferris. Their collaborative efforts have likely played a role in advancing the research and development of pharmaceutical solutions.

Conclusion

Anuj K Kuldipkumar stands out as an influential inventor in the pharmaceutical field, with a focus on innovative drug formulations and solid-state technologies. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…